Article Text

Download PDFPDF
Randomised controlled trial
Blood glucose monitoring had no impact on distress or self-efficacy in people with non-insulin-treated type 2 diabetes
  1. Simon R Heller
  1. University of Sheffield School of Medicine, Sheffield, UK
  1. Correspondence to : Professor Simon R Heller, University of Sheffield School of Medicine, Beech Hill Road, Sheffield S10 2RX, UK; s.heller{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on:


While it is generally accepted that blood glucose monitoring is an important component of treatment in the management of insulin-treated diabetes (both type 1 and type 2 diabetes), the role of blood glucose monitoring in those with type 2 diabetes treated by oral agents remains uncertain. Systematic reviews of randomised controlled trials have persistently failed to find benefits on blood glucose control or hypoglycaemia in people with type 1 diabetes.1 ,2 This emphasises the methodological challenges of establishing the value of self-monitoring of blood glucose in individuals with type 2 diabetes on oral agents, who are at …

View Full Text


  • Twitter Follow Simon Heller at @simonrheller

  • Competing interests None declared.